Remote Ischemic Postconditioning: Harnessing Endogenous Protection in a Murine Model of Vascular Cognitive Impairment

Translational Stroke Research

Volumn 6, Issue 1, 2015, Pages 69-77

  Khan, Mohammad Badruzzaman ^a,d   Hoda, Md Nasrul ^a,b,c,d   Vaibhav, Kumar ^b   Giri, Shailendra ^e   Wang, Philip ^a   Waller, Jennifer L ^b   Ergul, Adviye ^a,c,d   Dhandapani, Krishnan M ^a   Fagan, Susan C ^a,c,d   Hess, David C ^a,c  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b AUGUSTA UNIVERSITY   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e HENRY FORD HOSPITAL   (United States)

Author keywords

Arterial stenosis; Chronic cerebral hypoperfusion; Remote ischemic postconditioning; Transient ischemic attacks; Vascular cognitive impairment; White matter lesion

Indexed keywords

AMYLOID BETA PROTEIN; MYELIN BASIC PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILATERAL COMMON CAROTID ARTERY STENOSIS; BRAIN BLOOD FLOW; BRAIN PERFUSION; CAROTID ARTERY OBSTRUCTION; CELL DEATH; CELL VACUOLE; COGNITION; COGNITIVE DEFECT; INFLAMMATION; ISCHEMIC POSTCONDITIONING; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REMOTE LIMB ISCHEMIC POSTCONDITIONING; TREATMENT DURATION; VASCULAR COGNITIVE IMPAIRMENT; WHITE MATTER; ANIMAL; BRAIN CORTEX; BRAIN ISCHEMIA; C57BL MOUSE; CAROTID STENOSIS; COMPLICATION; DEMENTIA, VASCULAR; DISEASE MODEL; ENCEPHALITIS; METABOLISM; MYELIN SHEATH; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGY; RECOGNITION; VASCULARIZATION;

AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN ISCHEMIA; CAROTID STENOSIS; CELL DEATH; CEREBRAL CORTEX; DEMENTIA, VASCULAR; DISEASE MODELS, ANIMAL; ENCEPHALITIS; ISCHEMIC POSTCONDITIONING; MALE; MICE; MICE, INBRED C57BL; MYELIN SHEATH; RECOGNITION (PSYCHOLOGY); WHITE MATTER;

EID: 84921344340     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-014-0374-6     Document Type: Article

References (24)

1. Iadecola C. The pathobiology of vascular dementia. Neuron. 2013;80(4):844–66.
2. Libon DJ et al. Alzheimer’s “other dementia”. Cogn Behav Neurol. 2006;19(2):112–6.
3. Jellinger KA. Pathology and pathogenesis of vascular cognitive impairment-a critical update. Front Aging Neurosci. 2013;5:17.
4. Gorelick PB et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011;42(9):2672–713.
5. Iadecola C. The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol. 2010;120(3):287–96.
6. Poggesi A et al. 2001–2011: A decade of the LADIS (Leukoaraiosis And DISability) study: what have we learned about white matter changes and small-vessel disease? Cerebrovasc Dis. 2011;32(6):577–88.
7. Verdelho A et al. Physical activity prevents progression for cognitive impairment and vascular dementia: results from the LADIS (Leukoaraiosis and Disability) study. Stroke. 2012;43(12):3331–5.
8. Hess DC, Hoda MN, Bhatia K. Remote limb perconditioning and postconditioning: will it translate into a promising treatment for acute stroke? Stroke, 2013;44(4):1191–7.
9. Hoda MN, et. al. Remote ischemic perconditioning is effective after embolic stroke in ovariectomized female mice. Transl Stroke Res, 2014;5(4):484–90.
10. Hoda MN et al. Remote ischemic perconditioning is effective alone and in combination with intravenous tissue-type plasminogen activator in murine model of embolic stroke. Stroke. 2012;43(10):2794–9.
11. Meng R et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology. 2012;79(18):1853–61.
12. Bink DI et al. Mouse models to study the effect of cardiovascular risk factors on brain structure and cognition. J Cereb Blood Flow Metab. 2013;33(11):1666–84.
13. Shibata M et al. White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke. 2004;35(11):2598–603.
14. Schmidt R et al. White matter lesion progression in LADIS: frequency, clinical effects, and sample size calculations. Stroke. 2012;43(10):2643–7.
15. Wakade C et al. Delayed reduction in hippocampal postsynaptic density protein-95 expression temporally correlates with cognitive dysfunction following controlled cortical impact in mice. J Neurosurg. 2010;113(6):1195–201.
16. Mangalam A et al. Profile of circulatory metabolites in a relapsing-remitting animal model of multiple sclerosis using global metabolomics. J Clin Cell Immunol. 2013;4.
17. Hoda MN et al. Reduction of lipoxidative load by secretory phospholipase A2 inhibition protects against neurovascular injury following experimental stroke in rat. J Neuroinflammation. 2009;6:21.
18. Ma J et al. Protective effect of carnosine on subcortical ischemic vascular dementia in mice. CNS Neurosci Ther. 2012;18(9):745–53.
19. de la Torre JC, Aliev G. Inhibition of vascular nitric oxide after rat chronic brain hypoperfusion: spatial memory and immunocytochemical changes. J Cereb Blood Flow Metab. 2005;25(6):663–72.
20. Liu Q et al. White matter injury due to experimental chronic cerebral hypoperfusion is associated with C5 deposition. PLoS ONE. 2013;8(12):e84802.
21. Kitaguchi H et al. Chronic cerebral hypoperfusion accelerates amyloid beta deposition in APPSwInd transgenic mice. Brain Res. 2009;1294:202–10.
22. Ihara M, Tomimoto H. Lessons from a mouse model characterizing features of vascular cognitive impairment with white matter changes. J Aging Res. 2011;2011:978761.
23. Pantoni L et al. Leukoaraiosis predicts hidden global functioning impairment in nondisabled older people: the LADIS (Leukoaraiosis and Disability in the Elderly) Study. J Am Geriatr Soc. 2006;54(7):1095–101.
24. Inzitari D et al. Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort. BMJ. 2009;339:b2477.